One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Table of Contents
doi : 10.1016/S0190-9622(23)01090-3
Volume 89, Issue 2, August 2023, Pages A5-A6, A8, A10, A12, A14-A16, A26-A27, A32, A41
Information for Readers
doi : 10.1016/S0190-9622(23)01091-5
Volume 89, Issue 2, August 2023, Page A45
JAAD Case Reports Article List
doi : 10.1016/S0190-9622(23)01092-7
Volume 89, Issue 2, August 2023, Pages A46-A47, A52
Journal Based CME Instructions and Information
doi : 10.1016/S0190-9622(23)01093-9
Volume 89, Issue 2, August 2023, Page A54
Part I: Cutaneous manifestations of cardiovascular disease
Jamie Karch, RN, BSN, a Aishwarya Raja, BSc, b Henriette De La Garza, MD, c Antonio De Jesus Diaz Zepeda, BSc, d Allen Shih, MD, MBA, MA, c Mayra B. C. Maymone, DDS, MD, DSc, e Tania J. Phillips, MD, c Eric Secemsky, MD, MSc, f and Neelam Vashi, MD
doi : 10.1016/j.jaad.2021.06.902
Volume 89, Issue 2, August 2023, Pages 197-208
Answers to CME examination
doi : 10.1016/j.jaad.2023.06.013
Volume 89, Issue 2, August 2023, Page 210
Part II: Cutaneous manifestations of peripheral vascular disease
Aishwarya Raja, BSc, a Jamie Karch, RN, b Allen F. Shih, MD, MBA, MA, c Henriette De La Garza, MD, c Antonio Jesus De Zepeda Diaz, BSc, d Mayra B. C. Maymone, DDS, MD, DSc, e Tania J. Phillips, MD, c Eric Secemsky, MD, MSc, f and Neelam Vashi, MD
doi : 10.1016/j.jaad.2021.05.077
Volume 89, Issue 2, August 2023, Pages 211-226
Answers to CME examination
doi : 10.1016/j.jaad.2023.06.015
Volume 89, Issue 2, August 2023, Page 228
A call for demographic data to support diversity, equity, and inclusion efforts
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2023.05.013
Volume 89, Issue 2, August 2023, Page 229
This month in JAAD: August 2023
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2023.05.061
Volume 89, Issue 2, August 2023, Page 230
This month in JAAD Case Reports: August 2023: Xylazine and skin necrosis
Brett Sloan, MD
doi : 10.1016/j.jaad.2023.05.057
Volume 89, Issue 2, August 2023, Page 231
This Month in JAAD International: August 2023: Knowledge, attitudes, and perceptions relating to hidradenitis suppurativa
Jonathan Kantor, MD, MSc, MSCE
doi : 10.1016/j.jaad.2023.06.007
Volume 89, Issue 2, August 2023, Page 232
Confluent and reticulated papillomatosis, prurigo pigmentosa, and antibiotic preference
Warren R. Heymann, MD
doi : 10.1016/j.jaad.2023.05.066
Volume 89, Issue 2, August 2023, Pages 233-234
Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study
Pablo A. Jimenez, MD, a Howard L. Sofen, MD, b Robert Bissonnette, MD, c Mark Lee, MD, d Joseph Fowler, MD, e David J. Zammit, PhD, a Yusong Chen, PhD, a Niranjan Rao, PhD, a Louis Denis, MD, a and Sandeep Gupta, PhD
doi : 10.1016/j.jaad.2023.04.027
Volume 89, Issue 2, August 2023, Pages 235-242
Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study
Laurent Azoulay, PhD, a,b,c Audray St-Jean, MSc, c Matthew Dahl, BSc, d Jacqueline Quail, PhD, e Wusiman Aibibula, MD, PhD, f James M. Brophy, MD, PhD, a,g,h An-Wen Chan, MD, DPhil, i,j Lauren Bresee, PhD, k Greg Carney, PhD, l Sherif Eltonsy, PhD, m Hala Tamim, PhD, n,o J. Michael Paterson, MSc, j and Robert W. Platt, PhD, a,c,p for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators
doi : 10.1016/j.jaad.2023.04.035
Volume 89, Issue 2, August 2023, Pages 243-253
No difference in survival for primary cutaneous Merkel cell carcinoma after Mohs micrographic surgery and wide local excision
Kevin J. Moore, MD, MPH, a,b Manisha Thakuria, MD, a,c,d and Emily S. Ruiz, MD, MPH
doi : 10.1016/j.jaad.2023.04.042
Volume 89, Issue 2, August 2023, Pages 254-260
A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus
Gil Yosipovitch, MD, a Ahmed Awad, DO, b Robert H. Spencer, PhD, c Catherine Munera, PhD, c and Frederique Menzaghi, PhD
doi : 10.1016/j.jaad.2023.03.051
Volume 89, Issue 2, August 2023, Pages 261-268
Comparison of clinicopathologic features, survival, and demographics in sebaceous carcinoma patients with and without Muir-Torre syndrome
Nolan J. Maloney, MD, a Natasha C. Zacher, MD, a Kelsey E. Hirotsu, MD, a Neil Rajan, MD PhD, b,c Sumaira Z. Aasi, MD, a and Nour Kibbi, MD
doi : 10.1016/j.jaad.2023.03.032
Volume 89, Issue 2, August 2023, Pages 269-273
Malignancy rates through 5Â years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials
Andrew Blauvelt, MD, MBA, a Mark Lebwohl, MD, b Richard G. Langley, MD, c Katelyn Rowland, MS, ARNP, d Ya-Wen Yang, MD, e Daphne Chan, PhD, d Megan Miller, MPH, f Yin You, MS, f Jenny Yu, MD, f Diamant Tha?i, MD, g Peter Foley, MD, h and Kim A. Papp, MD, PhD
doi : 10.1016/j.jaad.2023.03.035
Volume 89, Issue 2, August 2023, Pages 274-282
Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skinDrs Pavel and Guttman-Yassky,
Madeline Kim, BA, a Ester Del Duca, MD, a,b Julia Cheng, BA, a Britta Carroll, BA, a Paola Facheris, MD, a Yeriel Estrada, BA, a Amy Cha, PharmD, c John Werth, PhD, c Robert Bissonnette, MD, d Karl Nocka, PhD, e Chuanbo Zang, PhD, c Ana B. Pavel, PhD, a and Emma Guttman-Yassky, MD, PhD
doi : 10.1016/j.jaad.2023.02.064
Volume 89, Issue 2, August 2023, Pages 283-292
Racial and ethnic underrepresentation in dermatology clinical trials
Jessica Mineroff, BS, a,b Julie K. Nguyen, MD, a,b and Jared Jagdeo, MD, MS
doi : 10.1016/j.jaad.2023.04.011
Volume 89, Issue 2, August 2023, Pages 293-300
A retrospective case series of Mohs micrographic surgery and interdisciplinary management of female genital skin cancers: Local recurrence rates and patient-reported outcomes
Shannon T. Nugent, BS, a Leela K. Raj, BA, b Nawar A. Latif, MD, MPH, MSCE, c Lori Cory, MD, MSCE, c Janos L. Tanyi, MD, PhD, c Stephen J. Kovach III, MD, d John P. Fischer, MD, MPH, d Joshua Fosnot, MD, d Ines C. Lin, MD, d Jeremy R. Etzkorn, MD, MS, b Thuzar M. Shin, MD, PhD, b Cerrene N. Giordano, MD, b H. William Higgins II, MD, MBE, b Joanna L. Walker, MD, b and Christopher J. Miller, MD
doi : 10.1016/j.jaad.2023.02.050
Volume 89, Issue 2, August 2023, Pages 301-308
Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review
Vivian Y. Shi, MD, a Winston Chamberlain, MD, PhD, b Elaine Siegfried, MD, c,d Cheryl Kraff-Cooper, MD, e Kenneth Beckman, MD, f,g Peter Lio, MD, h Amy S. Paller, MD, h,i and Eric Simpson, MD
doi : 10.1016/j.jaad.2023.01.043
Volume 89, Issue 2, August 2023, Pages 309-315
Treatment recommendations for acne-associated hyperpigmentation: Results of the Delphi consensus process and a literature review
Susan Taylor, MD, a Nada Elbuluk, MD, MSc, b Pearl Grimes, MD, c Anna Chien, MD, d Iltefat Hamzavi, MD, e Andrew Alexis, MD, MPH, f Noelani Gonzalez, MD, g Jonathan Weiss, MD, h Sewon Kang, MD, d and Seemal R. Desai, MD
doi : 10.1016/j.jaad.2023.02.053
Volume 89, Issue 2, August 2023, Pages 316-323
Physical urticaria: Clinical features, pathogenesis, diagnostic work-up, and management
Sheila M. McSweeney, MB, BSc, MSc, MRCP, a Evangelos A. A. Christou, MD, PgCert, MedEd, MRCP (UK), a Marcus Maurer, MD, b,c Clive E. Grattan, MA, MD, a Christos Tziotzios, MA, MPhil, MB, BChir (Cantab), PhD, a and John A. McGrath, MD
doi : 10.1016/j.jaad.2023.02.062
Volume 89, Issue 2, August 2023, Pages 324-337
Emerging treatments for itch in atopic dermatitis: A review
Angelina Labib, BS, Teresa Ju, BS, and Gil Yosipovitch, MD
doi : 10.1016/j.jaad.2023.04.057
Volume 89, Issue 2, August 2023, Pages 338-344
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort
Katrina Abuabara, MD, MA, MSCE, a Lawrence F. Eichenfield, MD, b Robert Bissonnette, MD, c Jonathan I. Silverberg, MD, PhD, d Jerry Bagel, MD, e Emma Guttman-Yassky, MD, PhD, f Diamant Thaci, MD, g Eric L. Simpson, MD, h John E. Harris, MD, PhD, i James Krueger, MD, PhD, j Daniela E. Myers, MPH, k Amy Gamelli, PhD, l Marina Milutinovic, MD, m Anne Parneix, MD, m Julie M. Crawford, MD, n Janet S. Hildebrand, MPH, n Breda Munoz, PhD, n and Amy S. Paller, MD
doi : 10.1016/j.jaad.2022.08.065
Volume 89, Issue 2, August 2023, Pages 345-347
Association of confluent and reticulated papillomatosis with obesity and resolution after treatment with doxycycline: A retrospective cohort study
Alyce M. Kuo, BS, Samir Kamat, BA, Tyler J. D’Ovidio, BS, Rebecca Z. Zhou, BA, Nicole Zatorski, BS, Nanette B. Silverberg, MD, and Justine Fenner, MD
doi : 10.1016/j.jaad.2023.01.050
Volume 89, Issue 2, August 2023, Pages 348-350
Disparities in melanoma outcomes in urban versus rural settings: An analysis from the Nebraska cancer registry 2001-2016
Elizabeth M. Mata, MSN, BS, a,b Natalia Trinidad, MPH, c Elliot Blue, MD, a Marissa Lobl, PhD, d Dillon Clarey, MD, a Cheng Zheng, PhD, e and Ashley Wysong, MD, MS a
doi : 10.1016/j.jaad.2023.02.057
Volume 89, Issue 2, August 2023, Pages 350-352
Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi study
Nicoline F. Post, MD, a Michelle A. Rodrigues, MD, PhD, b Cyetta Liong-A-Jin, BS, a Annelies Lommerts, MD, PhD, a Marwa Abdallah, MD, PhD, c Jung Min Bae, MD, PhD, d Marcel W. Bekkenk, MD, PhD, a Caio C. Silva de Castro, MD, PhD, e Viktioria Eleftheriadou, MD, PhD, f Samia Esmat, MD, PhD, g Khaled Ezzedine, MD, PhD, h Nanja van Geel, MD, PhD, i Iltefat Hamzavi, MD, PhD, j Giovanni Leone, MD PhD, k Amit G. Pandya, MD, PhD, l Thierry Passeron, MD, PhD, m Noufal Raboobee, MD, PhD, n Julien Seneschal, MD, PhD, o Steven Th’ng, MD, PhD, p and Albert Wolkerstorfer, MD PhD
doi : 10.1016/j.jaad.2023.03.015
Volume 89, Issue 2, August 2023, Pages 352-354
Characterizing cutaneous malignancies in patients with skin of color treated with Mohs micrographic surgery
Michelle C. Juarez, MD, a Maressa C. Criscito, MD, a Akshay Pulavarty, BA, MPH, b Mary L. Stevenson, MD, a and John A. Carucci, MD, PhD
doi : 10.1016/j.jaad.2023.03.018
Volume 89, Issue 2, August 2023, Pages 355-357
Use of Janus kinase inhibitors for granulomatous dermatoses: A systematic review
Siddhartha Sood, HBSc, a Martin Heung, b Jorge R. Georgakopoulos, MD, c Asfandyar Mufti, MD, c,d Vimal H. Prajapati, MD, e,f,g,h,i,j and Jensen Yeung, MD
doi : 10.1016/j.jaad.2023.03.024
Volume 89, Issue 2, August 2023, Pages 357-359
Alopecia areata and thyroid screening in Down syndrome: Leveraging epic cosmos data set
Allison Kranyak, MD, a Jillian Rork, MD, b,c Joshua Levy, PhD, a,d,e and Timothy E. Burdick, MD, MSc, MBA
doi : 10.1016/j.jaad.2023.03.026
Volume 89, Issue 2, August 2023, Pages 360-361
Recurrent reactive infectious mucocutaneous eruption: AÂ retrospective cohort study
Catherina X. Pan, BA, a,b and Sadaf Hashim Hussain, MD a,c
doi : 10.1016/j.jaad.2023.03.027
Volume 89, Issue 2, August 2023, Pages 361-364
Cutaneous neonatal lupus in patients with skin of color: AÂ retrospective cohort study from a national registry
Julianne Kleitsch, BA, a Daniel R. Mazori, MD, b Mala Masson, BA, c Peter M. Izmirly, MD, c Amit Saxena, MD, c Jill P. Buyon, MD, c and Sharon A. Glick, MD, MS
doi : 10.1016/j.jaad.2023.03.028
Volume 89, Issue 2, August 2023, Pages 364-366
Interleukin-17 pathway inhibition with brodalumab in early systemic sclerosis: Analysis of a single-arm, open-label, phase 1 trial
Takemichi Fukasawa, MD, a Ayumi Yoshizaki, MD, a Satoshi Ebata, MD, a Maiko FukayamaMD, a Ai Kuzumi, MD, a Yuta Norimatsu, MD, a Kazuki M. Matsuda, MD, a Hirohito Kotani, MD, a Hayakazu Sumida, MD, a Asako Yoshizaki- Ogawa, MD, a Hisashi Kagebayashi, MSc, b and Shinichi Sato, MD
doi : 10.1016/j.jaad.2023.02.061
Volume 89, Issue 2, August 2023, Pages 366-369
Incidence trends of melanoma among young adults: An epidemiologic study in Olmsted County, Minnesota
Olivia M. Crum, MD, a Elliott H. Campbell, MD, a Jacob P. Reinhart, MD, a Sydney L. Proffer, MD, MS, a Amy L. Weaver, MS, b Lawrence E. Gibson, Fig 1. Age-adjusted incidence of cutaneous melanoma per 100,000 person-years in Olmsted County, Minnesota from 1970-2020 for persons aged 18 to 39 years by sex and calendar period. Bars represent 95% CIs. J AM ACAD D ERMATOL V OLUME 89, NUMBER 2 Research Letters 369 MD, c Jerry D. Brewer, MD, MS, d and Addison M. Demer, MD
doi : 10.1016/j.jaad.2023.03.030
Volume 89, Issue 2, August 2023, Pages 369-370
Association of herpes zoster with COVID-19 vaccination: A systematic review and meta-analysis
I-Ling Chen, MD, a and Hsien-Yi Chiu, MD, PhD
doi : 10.1016/j.jaad.2023.03.031
Volume 89, Issue 2, August 2023, Pages 370-371
Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective
Jensen Yeung, MD, a,b,c,d Melinda J. Gooderham, MD, c,e,f H. Chih-Ho Hong, MD, c,g,h,i Charles Lynde, MD, c,j Vimal H. Prajapati, MD, k,l,m,n,o Perla Lansang, MD, a,b,d,p Irina Turchin, MD, c,q,r Marni Wiseman, MD, c,s,t Carolyn Jack, MD, u,v,w Michele Ramien, MD, k,x Kerri Purdy, MD, y and Parbeer Grewal, MD
doi : 10.1016/j.jaad.2023.01.053
Volume 89, Issue 2, August 2023, Pages 372-375
Risk factors for development of skin cancer differ between allogenic and autogenic hematopoietic stem cell transplant recipients
Chelsea Shope, MSCR, a Laura Andrews, MSCR, a Caroline Brailsford, MS, a and Lara Wine Lee, MD, PhD
doi : 10.1016/j.jaad.2023.03.033
Volume 89, Issue 2, August 2023, Pages 375-376
Prurigo pigmentosa: A multi-institutional retrospective study
Amy Shen, BS, a Carol E. Cheng, MD, a Rhea Malik, MS, b Erica Mark, BS, c Natalia Vecerek, MD, d Nolan Maloney, MD, e Joan Leavens, MD, f Vinod E. Nambudiri, MD, MBA, EdM, b Art P. Saavedra, MD, PhD, c Marcia Hogeling, MD, a and Scott Worswick, MD
doi : 10.1016/j.jaad.2023.03.034
Volume 89, Issue 2, August 2023, Pages 376-378
Long-term treatment outcomes and safety of dupilumab as a therapy for bullous pemphigoid: A multicenter retrospective review
Christine Learned, BA, a Stephanie R. Cohen, MD, a Kaitlynne Cunningham, BS, a Sarah Alsukait, MBBS, a Sueheidi Santiago, MD, b Jun Lu, MD, b Marti Rothe, MD, b Anna Nichols, MD, c and David Rosmarin, MD
doi : 10.1016/j.jaad.2023.03.036
Volume 89, Issue 2, August 2023, Pages 378-382
Epidemiology of tinea capitis causative species: An analysis of fungal culture results from a major United States national commercial laboratory
Jeremy A. W. Gold, MD, a Kaitlin Benedict, MPH, a Shawn R. Lockhart, PhD, a and Shari R. Lipner, MD, PhD
doi : 10.1016/j.jaad.2023.03.037
Volume 89, Issue 2, August 2023, Pages 382-384
Rosacea diagnosis and prescription patterns in underrepresented groups: An All of Us database analysis
Fadwa Ahmed, BS, a Sara D. Ragi, BS, a Isabelle Moseley, BA, a Fatima N. Mirza, MD, MPH, b Sara Yumeen, MD, b Terrence Vance, PhD, b Samantha Ouellette, BA, c and Babar Rao, MD
doi : 10.1016/j.jaad.2023.03.042
Volume 89, Issue 2, August 2023, Pages 384-385
Papillomas of Costello syndrome are not associated with human papillomavirus infection in a small case series
Gerilyn M. Olsen, MD, a Luke Johnson, MD, b Pau Castel, PhD, c David A. Stevenson, MD, d Kevin White, MD, e Yvonne E. Chiu, MD, f Alfons Krol, MD, e and Dawn H. Siegel, MD
doi : 10.1016/j.jaad.2023.03.043
Volume 89, Issue 2, August 2023, Pages 385-388
Artificial intelligence–derived dermatology case reports are indistinguishable from those written by humans: A single-blinded observer study
Charles Dunn, MD, a Jacob Hunter, MS, b William Steffes, MD, a Zackary Whitney, DO, a Michael Foss, DO, a Jere Mammino, DO, a Adam Leavitt, MD, a Spencer D. Hawkins, MD, c Alexander Dane, DO, a Martin Yungmann, DO, a and Rajiv Nathoo, MD
doi : 10.1016/j.jaad.2023.04.005
Volume 89, Issue 2, August 2023, Pages 388-390
Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea
Amy J. Petty, MD, PhD, a Drew A. Emge, MD, MSc, a Sarah K. Blanchard, MD, a Maria Angelica Selim, MD, b Kim Scoggins, RN, a Beiyu Liu, PhD, c Cynthia L. Green, PhD, c and Adela R. Cardones, MD, MHSc
doi : 10.1016/j.jaad.2023.03.052
Volume 89, Issue 2, August 2023, Pages 390-392
Disparities between Asian groups in time to melanoma treatment: AÂ cross-sectional study
Lauren S. Fane, BSE, a Angela H. Wei, MS, b Raghav Tripathi, MD, MPH, c and Jeremy S. Bordeaux, MD, MPH
doi : 10.1016/j.jaad.2023.03.053
Volume 89, Issue 2, August 2023, Pages 392-394
Gender and leadership: Continued progress in academic dermatology
Preetha Kamath, MD, a Nallammai Muthiah, BS, b Anisha Venkatesh, MS, b and Melissa Pugliano- Mauro, MD
doi : 10.1016/j.jaad.2023.03.054
Volume 89, Issue 2, August 2023, Pages 394-396
Number needed to biopsy for longitudinal melanonychia: A retrospective review
Alexandra M. Bender, MD, PhD, Ania Stolarczyk, BS, and Kathleen A. Mannava, MD
doi : 10.1016/j.jaad.2023.04.006
Volume 89, Issue 2, August 2023, Pages 396-397
Decreased incidence of Merkel cell carcinoma in the younger population (aged below 50Â years) in the United States: SEER analysis 2000-2019
Andre S. Alves, BS, Matteo Scampa, MD, Jer^ome Martineau, MD, Daniel F. Kalbermatten, MD, PhD, and Carlo M. Oranges, MD, PhD
doi : 10.1016/j.jaad.2023.04.008
Volume 89, Issue 2, August 2023, Pages 397-399
Single-institution retrospective study evaluating personal history of rosacea and risk of basal cell carcinoma of the face
Erica M. Lin, BS, a Abrar A. Qureshi, MD, MPH, a,b Oliver Wisco, DO, a and Eunyoung Cho, ScD
doi : 10.1016/j.jaad.2023.03.055
Volume 89, Issue 2, August 2023, Pages 399-401
Comparative effectiveness of 5-aminolevulinic acid photodynamic therapy with no incubation versus one-hour incubation for the treatment of actinic keratosis: A randomized controlled trial
Noor Anvery, BA, a Rachel E. Christensen, BS, a McKenzie A. Dirr, BA, BS, a Michael D. Yi, BS, a Tyler Johnson, PA-C, a Alexandra Weil, BA, a Rachel Kyllo, MD, a Sabina Raja, BA, a Matthew Rapcan, BS, a Joaquin C. Brieva, MD, a Simon S. Yoo, MD, a Emily Poon, PhD, a and Murad Alam, MD, MBA, MSCI
doi : 10.1016/j.jaad.2023.03.056
Volume 89, Issue 2, August 2023, Pages 401-403
Predictors of palliative care receipt in Merkel cell carcinoma
Melika Marani, BS, Raghav Tripathi, MD, MPH, and Jeffrey F. Scott, MD
doi : 10.1016/j.jaad.2023.04.013
Volume 89, Issue 2, August 2023, Pages 403-404
From the Cochrane Library: Interventions for pityriasis rosea
Annie L. Cao, BS, a Madeline Adelman, MD, a Torunn E. Sivesind, MD, a Jose Contreras-Ruiz, MD, b Sandra Peternel, MD, PhD, c and Robert P. Dellavalle, MD, PhD, MSPH
doi : 10.1016/j.jaad.2023.04.014
Volume 89, Issue 2, August 2023, Pages 404-406
Prevalence of tuberculosis in patients with prurigo nodularis: A multicenter cross-sectional study
Hannah L. Cornman, BS, a Anusha Kambala, BS, a Shihua Chen, BS, a Jingyi Zhang, BS, a Sriya V. Reddy, BS, b and Shawn G. Kwatra, MD
doi : 10.1016/j.jaad.2023.04.015
Volume 89, Issue 2, August 2023, Pages 406-408
Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study
Patrick Michael Jedlowski, MD, Mahdieh F. Jedlowski, MD, PharmD, and Mohammad Fazel, MD, PharmD
doi : 10.1016/j.jaad.2023.03.057
Volume 89, Issue 2, August 2023, Pages 408-410
Differences in the tumor immunity-related gene expression profile between acral lentiginous and nonacral melanoma
Myoung Eun Choi, MD, Hee Joo Yang, MD, Chong Hyun Won, MD, PhD, Sung Eun Chang, MD, PhD, Mi Woo Lee, MD, PhD, and Woo Jin Lee, MD, PhD
doi : 10.1016/j.jaad.2023.03.058
Volume 89, Issue 2, August 2023, Pages 411-413
C3d immunohistochemistry in the diagnosis of bullous pemphigoid: A comparative diagnostic test accuracy and cost analysis study
Lily Guo, BS, MS, a Rebecca Jacobson, BM, b Heidi Vaughan, BSN, c M. Kari Connolly, MD, b,d Kira Seiger, MD, MBA, b Anna K. Haemel, MD, b and Jeffrey North, MD
doi : 10.1016/j.jaad.2023.04.016
Volume 89, Issue 2, August 2023, Pages 413-415
Efficacy, safety, and treatment patterns of ruxolitinib 1.5% cream in adult atopic dermatitis: A single center retrospective study
Nicole S. Stefanko, MD, Victor L. Quan, MD, and Raj Chovatiya, MD, PhD
doi : 10.1016/j.jaad.2023.04.029
Volume 89, Issue 2, August 2023, Pages 415-417
Management of adult generalized pustular psoriasis using biologics: A systematic review
Abrahim Abduelmula, BScN, a Brian D. Rankin, MD, PhD, b Siddhartha Sood, HBSc, c Jorge R. Georgakopoulos, MD, d Asfandyar Mufti, MD, d Ronald Vender, MD, e,f Jensen Yeung, MD, d,g,h,i and Vimal H. Prajapati, MD
doi : 10.1016/j.jaad.2023.04.031
Volume 89, Issue 2, August 2023, Pages 417-419
Retrospective analysis of management concordance between primary care providers and teledermatologists after electronic consultation
Colby A. Foster, BSE, a,b Ahab Chopra, BA, a,b and Milad Eshaq, MD
doi : 10.1016/j.jaad.2023.04.038
Volume 89, Issue 2, August 2023, Pages 419-422
Alopecia areata is associated with risk of inflammatory arthritis
Colin M. Kincaid, BS, Ajay N. Sharma, MD, and Natasha A. Mesinkovska, MD, PhD
doi : 10.1016/j.jaad.2023.04.039
Volume 89, Issue 2, August 2023, Pages 422-423
Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials
Riley K. Spencer, MA, a,b Joy Q. Jin, AB, a,c Kareem G. Elhage, BA, a Mitchell S. Davis, MD, a Marwa Hakimi, MD, a Tina Bhutani, MD, MAS, a and Wilson Liao, MD
doi : 10.1016/j.jaad.2023.04.043
Volume 89, Issue 2, August 2023, Pages 423-425
Prevalence of polycystic ovarian syndrome among children and adolescents with hidradenitis suppurativa
Nicole Mastacouris, MS, Andrew Strunk, MA, and Amit Garg, MD
doi : 10.1016/j.jaad.2023.04.044
Volume 89, Issue 2, August 2023, Pages 425-427
Epidemiology of implantation mycoses in the United States: An analysis of commercial insurance claims data, 2017 to 2021
Jeremy A. W. Gold, MD, a Dallas J. Smith, PharmD, a,b Kaitlin Benedict, MPH, a Shawn R. Lockhart, PhD, a and Shari R. Lipner, MD, PhD
doi : 10.1016/j.jaad.2023.04.048
Volume 89, Issue 2, August 2023, Pages 427-430
Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study
Elena Pezzolo, MD, a,b Alessio Gambardella, MD, c Mario Guanti, MD, d Tommaso Bianchelli, MD, e Alberto Bertoldi, MD, f Alfredo Giacchetti, MD, e Massino Donini, MD, f Giuseppe Argenziano, MD, PhD, c and Luigi Naldi, MD
doi : 10.1016/j.jaad.2023.04.056
Volume 89, Issue 2, August 2023, Pages 430-432
A case against in-office sales of skin care products
Benjamin K. Stoff, MD, MA
doi : 10.1016/j.jaad.2019.07.111
Volume 89, Issue 2, August 2023, Pages 433-434
Oxybenzone and pregnancy: Time for more research and patient education
Kate V. Viola, MD, MHS, a and Jane M. Grant-Kels, MD
doi : 10.1016/j.jaad.2021.11.049
Volume 89, Issue 2, August 2023, Pages 435-436
Ethics regarding the removal of benign melanocytic nevi in children
Alexander Gitin, BS,a Arthur M. Samia, MD, b Jane M. Grant-Kels, MD, c and Sami K. Saikaly, MD
doi : 10.1016/j.jaad.2022.05.045
Volume 89, Issue 2, August 2023, Pages 437-438
Beyond JAAD - July 2023
Andrew Bronin, MD
doi : 10.1016/j.jaad.2023.04.025
Volume 89, Issue 2, August 2023, Pages 439-442
Fibrosing vasculitides: A heuristic for investigation
Audrey Rutherford, BA, a Stephen Erickson, BS, b Emily Keimig, MD, c and Heather W. Wickless, MD, MPH
doi : 10.1016/j.jaad.2018.02.072
Volume 89, Issue 2, August 2023, Pages e71-e74
Wood's light examination for assessment in frontal fibrosing alopecia: A maneuver to enhance the hairline
Aizuri Murad, MRCS, MRCP, a and Wilma Bergfeld, MD b,c
doi : 10.1016/j.jaad.2019.11.065
Volume 89, Issue 2, August 2023, Pages e75-e76
Periosteal tacking sutures to facilitate primary repair of eyebrow-adjacent Mohs defects
Kevin Y. Shi, MD, PhD, a Andrew J. Matsumoto, MD, b and Rajiv I. Nijhawan, MD a
doi : 10.1016/j.jaad.2023.02.043
Volume 89, Issue 2, August 2023, Pages e77-e78
Using sterile adhesive bandages to maintain a sterile field during dermatologic surgery
Paul Curtiss, MD, Derek Davis, CMA, Divya Srivastava, MD, and Rajiv I. Nijhawan, MD
doi : 10.1016/j.jaad.2021.04.043
Volume 89, Issue 2, August 2023, Pages e79-e80
Correction of alar rim protrusion after direct closure of small alar defects
Juan Jimenez-Cauhe, MD, Sonia Bea-Ardebol, MD, PhD, Diego Fernandez-Nieto, MD, Daniel Ortega-Quijano, MD, and Luis Rios-Buceta, MD, PhD
doi : 10.1016/j.jaad.2021.04.064
Volume 89, Issue 2, August 2023, Pages e81-e82
Spring forceps as applicator stand
Bernard M. H. Liang, BDS, Meng
doi : 10.1016/j.jaad.2021.04.095
Volume 89, Issue 2, August 2023, Page e83
A simple method for fixing surgical sharps
Weilin Cai, MD, and Jianzhong Peng, MD
doi : 10.1016/j.jaad.2021.04.099
Volume 89, Issue 2, August 2023, Page e85
Novel noncontact bolster technique for graft preservation
Rachel Wetstone, MPH, a Miranda Rosenberg, MD, b and Martin Zaiac, MD
doi : 10.1016/j.jaad.2021.05.033
Volume 89, Issue 2, August 2023, Pages e87-e88
Modified technique of intralesional radiofrequency with drug deposition in keloids using customized intravenous cannulas
Neha Taneja, MD, Rhea Ahuja, MBBS, and Somesh Gupta, MD
doi : 10.1016/j.jaad.2021.05.037
Volume 89, Issue 2, August 2023, Pages e89-e90
It is not necessary to remove the nail plate during biopsy of the nail matrix
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2023.03.050
Volume 89, Issue 2, August 2023, Page e91
Smartphone dermoscopy with linear polarizers and light reflector
Bernard M. H. Liang, BDS, Meng
doi : 10.1016/j.jaad.2021.12.035
Volume 89, Issue 2, August 2023, Pages e93-e94
Estrogen could also play a key role in the development of pediatric melanoma
Elisabetta Magnaterra, MD, a Biancamaria Zuccaro, MD, a Manfredi Magliulo, MD, a Federico Venturi, MD, a Flavia Silvestri, MD, a Massimo Gola, MD, a and Vincenzo De Giorgi, MD
doi : 10.1016/j.jaad.2023.01.051
Volume 89, Issue 2, August 2023, Pages e95-e96
Reply to: “Estrogen could also play a key role in the development of pediatric melanoma�
Mary-Ann El Sharouni, PhD, a,b Serigne N. Lo, PhD, a,c Richard A. Scolyer, MD, a,c,d Carla H. van Gils, PhD, e and John F. Thompson, MD
doi : 10.1016/j.jaad.2023.03.008
Volume 89, Issue 2, August 2023, Pages e97-e98
Skin ulcerations caused by xylazine: A lesser-known entity
Anuradha Bishnoi, MD, a Vaneet Singh, MD, b Urmi Khanna, MD, c and Keshavamurthy Vinay, MD, DNB
doi : 10.1016/j.jaad.2023.04.009
Volume 89, Issue 2, August 2023, Pages e99-e102
Response to Nguyen et al: “A plea for involving American Indian researchers and allies in research and manuscript reviews�
Drew Hicks, MS, RD, a Spero M. Manson, PhD, b and Lucinda L. Kohn, MD, MHS
doi : 10.1016/j.jaad.2023.04.040
Volume 89, Issue 2, August 2023, Pages e103-e104
Safer 1064 nm long-pulse frequency settings and safety eyewear setup to improve visualization of superficial veins
Eric J. Yang, MD, a Sarah P. F. Wambier, MD, PhD, b and Carlos Gustavo Wambier, MD, PhD
doi : 10.1016/j.jaad.2023.02.067
Volume 89, Issue 2, August 2023, Pages e105-e106
Response to Felmingham C. et al's “Improving Skin cancer Management with ARTificial intelligence (SMARTI): A pre-post intervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a real-world specialist dermatology setting�
Eugene Tan, MBChB, a David Lim, MBChB, a and Frank Lin, MBChB, PhD
doi : 10.1016/j.jaad.2023.03.062
Volume 89, Issue 2, August 2023, Page e107
August 2023 iotaderma (#353)
Robert I. Rudolph, MD, FACP
doi : 10.1016/j.jaad.2023.02.005
Volume 89, Issue 2, August 2023, Page e109
